Related Experiment Videos
von Willebrand factor and cardiovascular disease
L Badimon1, J J Badimon, J H Chesebro
1Cardiovascular Research Unit & Foundation, CSIC-Sant Pau, Barcelona, Spain.
Thrombosis and Haemostasis
|July 1, 1993
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
HDL therapy today: from atherosclerosis, to stent compatibility to heart failure.
Annals of medicine·2019
LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Drugs of today (Barcelona, Spain : 1998)·2019
Dual versus triple antithrombotic therapy: is there a role for direct oral anticoagulants in arterial thrombosis?
Drugs of today (Barcelona, Spain : 1998)·2019
Muramidase: A useful monocyte/macrophage immunocytochemical marker in swine, of special interest in experimental cardiovascular disease.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
Platelet function normalization after a prasugrel loading-dose: time-dependent effect of platelet supplementation.
Journal of thrombosis and haemostasis : JTH·2012
Clinical Validation of a Point-of-Care Whole Blood Coagulometer in Patients on Factor Xa Inhibitors.
Thrombosis and haemostasis·2026
Rotem Platelet Component (A5 Platelet) as a Rapid Marker of Thrombocytopenia after Severe Trauma.
Thrombosis and haemostasis·2026